Area of research
Oncology · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, Cancer Cells and Metastasis, Lung Cancer Treatments and Mutations, and Inflammatory mediators and NSAID effects.
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer
The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assay
Phase I Trial of Intratumoral Injection of<i>CCL21</i>Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer
Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties
Molecular Profiling of Premalignant Lesions in Lung Squamous Cell Carcinomas Identifies Mechanisms Involved in Stepwise Carcinogenesis
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis
Enriching the Molecular Definition of the Airway “Field of Cancerization:” Establishing New Paradigms for the Patient at Risk for Lung Cancer